Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: Andreas Helke who wrote (824)	6/24/1998 8:01:00 AM
From: Dr. John M. de Castro	Read Replies (1) \| Respond to of 887

The interesting part of the downsizing announcement: biz.yahoo.com is the mention of depobupivicaine. I've thought for a while that this had great potential. But, it was buried so deep in the pipeline that I thought that DEPO had forgotten it. If they are going to focus resources on DepoMorphine and DepoBupivicaine then I am encouraged. These are both potential cash cows for the future. John de C

To: Andreas Helke who wrote (824)	6/24/1998 2:17:00 PM
From: StockDoc	Respond to of 887

You're right, indeed, I checked the news, they laid off some 40 people or so. How would the street know whether DEPO cut fat or muscle? The street new nothing about them ever. The previous cut was more like a mixture of lobotomy and face lift. Based on their former performance, I'd expect a random combo of surgery and autopsy. Nevertheless, it may help them doing something with their neat technology. I'm not really following this stock any longer but thanks for the update anyway.